GLAXOSMITHKLINE PHARMACEUTICALS
Back to Balance Sheet
|
GLAXOSMITHKLINE PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Sundry Debtors | ₹192 Cr | ₹205 Cr | ₹216 Cr | ₹100 Cr | ₹120 Cr |
What is the latest Sundry Debtors ratio of GLAXOSMITHKLINE PHARMACEUTICALS ?
Year | Sundry Debtors |
---|---|
Mar2023 | ₹192 Cr |
Mar2022 | ₹205 Cr |
Mar2021 | ₹216 Cr |
Mar2020 | ₹100 Cr |
Mar2019 | ₹120 Cr |
How is Sundry Debtors of GLAXOSMITHKLINE PHARMACEUTICALS Trending?
Years | Sundry Debtors | % Change | |
---|---|---|---|
Mar2023 | ₹192 Cr | -6.27 | |
Mar2022 | ₹205 Cr | -4.81 | |
Mar2021 | ₹216 Cr | 116.03 | |
Mar2020 | ₹100 Cr | -17.17 | |
Mar2019 | ₹120 Cr | - |
Compare Sundry Debtors of peers of GLAXOSMITHKLINE PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GLAXOSMITHKLINE PHARMACEUTICALS | ₹41,171.0 Cr | 3.2% | 16.9% | 90.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹356,673.0 Cr | -2.9% | 0% | 59.6% | Stock Analytics | |
CIPLA | ₹119,930.0 Cr | 5.8% | 6.2% | 60.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹109,446.0 Cr | 5% | 8% | 25.9% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹108,261.0 Cr | -2.6% | 15.3% | 114.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,830.6 Cr | 0.9% | -1.5% | 32.2% | Stock Analytics |
GLAXOSMITHKLINE PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GLAXOSMITHKLINE PHARMACEUTICALS | 3.2% |
16.9% |
90.5% |
SENSEX | 2% |
2.3% |
22.2% |
You may also like the below Video Courses